Home
Home » companies

Merck

Will the FDA Wake Up to This Drug's Potential?

Will the FDA Wake Up to This Drug's Potential?
Motley Fool

Can Merck Field a Psoriasis Blockbuster?

Can Merck Field a Psoriasis Blockbuster?
Motley Fool

Merck & Co: Growth Will Become Stagnant

Merck & Co: Growth Will Become Stagnant
Seeking Alpha

This Week in Biotech

This Week in Biotech
Motley Fool

India's top court rebuffs Merck, lets generic Januvia roll out

India's top court rebuffs Merck, lets generic Januvia roll out
Fierce Pharma

A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation

A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation
Seeking Alpha

3 Ways Big Pharma Is Seizing This Rare Opportunity

3 Ways Big Pharma Is Seizing This Rare Opportunity
Motley Fool

Experimental sleep drug may cause fewer side effects -Merck study

Experimental sleep drug may cause fewer side effects -Merck study
Reuters

Merck’s Fosamax on Trial Again After First Case Halted

Merck’s Fosamax on Trial Again After First Case Halted
Bloomberg

A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs

A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha